KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹33 Cr | ₹33 Cr | ₹34 Cr | ₹40 Cr | ₹46 Cr |
What is the latest Total Non-Current Liabilities ratio of KOPRAN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹33 Cr |
Mar2022 | ₹33 Cr |
Mar2021 | ₹34 Cr |
Mar2020 | ₹40 Cr |
Mar2019 | ₹46 Cr |
How is Total Non-Current Liabilities of KOPRAN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹33 Cr | 1.05 | |
Mar2022 | ₹33 Cr | -1.59 | |
Mar2021 | ₹34 Cr | -16.83 | |
Mar2020 | ₹40 Cr | -12.33 | |
Mar2019 | ₹46 Cr | - |
Compare Total Non-Current Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,179.9 Cr | -7.3% | -9.7% | 63.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -7.3% |
-9.7% |
63.2% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses